ArticleInfection prevention in practice2026
Incidence and prevention of postprocedural bacteraemia and complications following water vapour therapy of the prostate: a retrospective review and quality improvement initiative at a tertiary care centre.
Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Water vapour therapy of the prostate is a minimally invasive treatment for benign prostatic hyperplasia. While generally safe, rare but clinically significant complications, such as postprocedural bacteraemia, have been reported. Differentiating true complications from expected side-effects is essential for accurate risk communication and quality improvement. Objective: The aim of this study was to evaluate the incidence of bacteraemia and other adverse events following these treatments and assess the impact of targeted interventions on patient safety. Methods: A retrospective review was conducted of all procedures performed at Cleveland Clinic Abu Dhabi between January 2021 and December 2025. The pre-intervention cohort included 82 cases, and the postintervention cohort included 46 cases. Outcomes were classified as complications or side-effects. Interventions initiated in Q3 2023 included standardized operating procedures, revised antibiotic prophylaxis, and enhanced patient education. Risk differences, relative risks, and P-values were calculated using Fisher's exact test. Results: Before the intervention, bacteraemia occurred in 6.1% of cases and urinary tract infections (UTIs) in 6.1%. Following implementation, no cases of bacteraemia or UTIs were observed in the postintervention cohort (0/46), representing a reduction compared with the pre-intervention period. A single case of candiduria emerged in the postintervention cohort (1/46; 2.2%), with no evidence of a sustained increase in fungal complications. Urinary retention decreased from 6.1% to 0. Haematuria remained relatively stable, increasing from 13.4% to 15.2%. Dysuria decreased from 19.5% to 8.7%. Although statistical significance was not achieved, these findings indicate clinically meaningful improvement. Conclusion: Protocolized antimicrobial prophylaxis, standardized workflows, and patient education were associated with reduced infectious complications and improved safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.